Executive Summary The Global Injectable Drugs Market was valued at USD 414.88 Billion in the year 2020. Increasing prevalence of diseases such as diabetes, cancer and auto-immune disorders like rheumatoid arthritis and multiple sclerosis with an upsurge in the number of chronic diseases have driven the need for drug delivery systems and a higher demand for Injectable drugs. Increasing use of self-administered Injectable formulations like auto injectors, pen injectors, pre-filled syringes (PFS) and needle-free injectors has led to greater acceptance of Injectables.
The injectable drugs market is characterised by regulatory challenges, the pricing pressures, patent expiries and drug shortages. Major demand in complex segments such as large molecule peptides and vaccines couple with the shortage of injectables in the United States holds major opportunities for the injectables market. The large molecule injectable drugs market is projected to grow at a rapid pace in the next few years. Increase in the geriatric population and rise in prevalence of chronic diseases such as diabetes and cancer are the key factors driving the market.
North America dominates the Injectable Drugs market, owing to rapid developments in healthcare infrastructure, the presence of major players in the region, huge investments made in the research and development, and increased adoption of oncology-related drugs in hospitals to treat different cancers.
Asia Pacific region is expected to register the fastest growth in global injectable market during the forecast period. Additionally, there is an increase in the number of new drug formulations which are less water soluble and/or have very low permeability to allow for adequate absorption from the gastrointestinal tract following oral administration. The only way to make such drugs available in the body is through an intravenous administration.
Scope of the Report • The report presents the analysis of Injectable Drugs market for the historical period of 2016-2020 and the forecast period of 2021-2026.
• The report analyses the Injectable Drugs Market by value (USD Billion).
• The report analyses the Injectable Drugs Market by Product (Complex Biologics, Conventional Therapeutic, Vaccines, Insulin).
• The report analyses the Injectable Drugs Market by Molecule (Small Molecule, Large Molecule).
• The report analyses the Injectable Drugs Market by Delivery (Prefilled Syringe, Infusions, Others).
• The Global Injectable Drugs Market has been analysed By Region (North America Europe, Asia Pacific, MEA) By Country (United States, Canada, Germany, U.K, France, Italy, China, Japan, India, South Korea).
• The key insights of the report have been presented through the frameworks of the attractiveness of the market has been presented by region, by product, By Molecule, By Delivery
• Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Johnson & Johnson, Pfizer, GlaxoSmithKline, Novartis, Eli Lilly and Company, AstraZeneca Plc, Sanofi, Merck KGaA, Novo Nordisk, Baxter International.
Key Target Audience
• Healthcare and Pharmaceutical Companies
• Consulting and Advisory Firms
• Government and Policy Makers
• Regulatory Authorities
Our reports have been used by over 10K customers, including:
The pen needles market is expected to reach USD 2.2 Billion by 2026 from an estimated USD 1.3 Billion in 2021, at a CAGR of 11.2%. Growth in the market is largely driven by the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. On the other hand, the preference for alternative modes of drug...
The global esoteric testing market is projected to reach USD 36.3 billion by 2026 from USD 21.0 billion in 2021, at a CAGR of 11.6% during the forecast period. Market growth is largely driven by the rising incidence of chronic and infectious diseases, increasing use of esoteric DNA sequencing technologies in precision medicine, early diagnosis...
Executive Summary Global Hexamethyldisilazane Market was valued at USD 202.32 Million and xx Kilotonne by volume in the year 2020. Hexamethyldisilane (HMDS) is an organosilicon compound used as a reagent or precursor to bases and is primarily used as a silylating agent in the process of manufacturing pharmaceutical drugs...
The near-infrared imaging market size is expected to grow from an estimated USD 0.8 billion in 2021 to USD 1.6 billion by 2026, at a CAGR of 14.0%. The growing number of surgical procedures performed globally, advantages of NIR imaging over conventional visualization methods, and technological advancements in NIR imaging modalities. However,...
The North America healthcare gamification market is expected to reach US$ 14,986.79 million by 2027 from US$ 1,260.40 million in 2019. The market is estimated to grow at a CAGR of 36.3% 2019-2027. The growth of the market is attributed to factors such as increasing adoption of gamification in healthcare and rising number of technology launches....
Urinalysis market is expected to exibhit a growth of 7.5% CAGR during the forecast period. The higher burden of chronic diseases and rising adaptation of point of care testing is expected to be the major contributing factors for the market growth. Urinary tract infection refers to the infection in any part of the urinary system. According...
408 pages •
By Global Industry Analysts
• May 2021
Global Digital Health Market to Reach $456.9 Billion by 2026
Digital health uses communication technologies and information for various healthcare processes, including for research, early diagnosis of health conditions, and enhancing an individual`s overall health and well-being....
296 pages •
By The Business Research Company
• Mar 2021
Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global vascular endothelial growth factor (VEGF) inhibitor market. Description: Where...
Executive Summary The Covid-19 pandemic has restricted the movement of people, confining them in their homes, caused severe trauma and stress in the form of sadness and loneliness and has affected the mental health of individuals. As a result, in many countries, people are facing medical conditions like depression and anxiety....
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Personalized Nutrition Market Report
The personalized nutrition market is expected to grow at a CAGR of over 16% during 2021-2026.
Increasing disposable income in the developing regions and fast integration of digital healthcare technologies...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.